Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis

Journal of Clinical Investigation

Volumn 124, Issue 4, 2014, Pages 1537-1551

  Keeton, Roanne ^a   Allie, Nasiema ^a   Dambuza, Ivy ^a   Abel, Brian ^a,b   Hsu, Nai Jen ^a   Sebesho, Boipelo ^a   Randall, Philippa ^a   Burger, Patricia ^a   Fick, Elizabeth ^a   Quesniaux, Valerie F J ^c   Ryffel, Bernhard ^c   Jacobs, Muazzam ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b AGENCY FOR SCIENCE   (Singapore)

^c UNIVERSITÉ D'ORLÉANS   (France)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12P40; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 75; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; GRANULOMA; HOST RESISTANCE; IMMUNOREGULATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TUBERCULOSIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; GRANULOMA; HOST-PATHOGEN INTERACTIONS; INTERLEUKIN-12 SUBUNIT P40; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; SOLUBILITY; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897568609     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI45005     Document Type: Article

References (54)

1. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104(4):487-501. (Pubitemid 32201945)
2. Schluter D, Deckert M. The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Infect. 2000;2(10):1285-1292.
3. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell. 1990;63(2):251-258.
4. Orlinick JR, Chao MV. TNF-related ligands and their receptors. Cell Signal. 1998;10(8):543-551. (Pubitemid 28438330)
5. Wajant H, Scheurich P. Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. Int J Biochem Cell Biol. 2001;33(1):19-32. (Pubitemid 32146464)
6. Corti A, et al. Upregulation of p75 tumor necrosis factor α receptor in Mycobacterium avium-infected mice: evidence for a functional role. Infect Immun. 1999;67(11):5762-5767. (Pubitemid 29508096)
7. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-±. J Immunol. 1998;161(5):2636-2641. (Pubitemid 28397084)
8. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med. 1992;175(2):323-329.
9. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002;168(9):4620-4627. (Pubitemid 34441368)
10. Kaneko H, et al. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-α- deficient mice. Lab Invest. 1999;79(4):379-386. (Pubitemid 29190427)
11. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989;56(5):731-740. (Pubitemid 19082507)
12. Eriks IS, Emerson CL. Temporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium avium. Infect Immun. 1997;65(6):2100-2106. (Pubitemid 27237284)
13. Bean AG, et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol. 1999;162(6):3504-3511. (Pubitemid 29313602)
14. Zganiacz A, et al. TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest. 2004;113(3):401-413. (Pubitemid 38544184)
15. Jacobs M, et al. Reactivation of tuberculosis by tumor necrosis factor neutralization. Eur Cytokine Netw. 2007;18(1):5-13. (Pubitemid 46848053)
16. Jacobs M, et al. Tumor necrosis factor is critical to control tuberculosis infection. Microbes Infect. 2007;9(5):623-628. (Pubitemid 46628779)
17. Fremond C, et al. Membrane TNF confers protection to acute mycobacterial infection. Respir Res. 2005;6:136.
18. Olleros ML, et al. Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-α. J Immunol. 2002;168(7):3394-3401. (Pubitemid 34250403)
19. Olleros ML, et al. Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections. Am J Pathol. 2005;166(4):1109-1120. (Pubitemid 40524435)
20. Probert L, et al. Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice. J Leukoc Biol. 1996;59(4):518-525. (Pubitemid 26156614)
21. Saunders BM, Tran S, Ruuls S, Sedgwick JD, Briscoe H, Britton WJ. Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol. 2005;174(8):4852-4859.
22. Allie N, et al. Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection. Immunology. 2008;125(4):522-534.
23. Dambuza I, et al. Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence. Tuberculosis (Edinb). 2008;88(3):221-234. (Pubitemid 351635899)
24. Flynn JL, et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995;2(6):561-572.
25. Jacobs M, et al. Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation. Lab Invest. 2000;80(6):901-914. (Pubitemid 30421807)
26. Senaldi G, Yin S, Shaklee CL, Piguet PF, Mak TW, Ulich TR. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J Immunol. 1996;157(11):5022-5026. (Pubitemid 126449582)
27. Garcia I, et al. Lethal Mycobacterium bovis Bacillus Calmette Guerin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2. Lab Invest. 2000;80(9):1385-1397.
28. Moreira AL, Wang J, Sarno EN, Kaplan G. Thalidomide protects mice against LPS-induced shock. Braz J Med Biol Res. 1997;30(10):1199-1207.
29. Engele M, et al. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J Immunol. 2002;168(3):1328-1337. (Pubitemid 34094503)
30. -/- mice is dependent on T cells and IL-12. J Immunol. 2000;165(1):483-492.
31. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol. 1995;155(5):2515-2524.
32. Peschon JJ, et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol. 1998;160(2):943-952. (Pubitemid 28049339)
33. Jacobs M, Brown N, Allie N, Chetty K, Ryffel B. Tumor necrosis factor receptor 2 plays a minor role for mycobacterial immunity. Pathobiology. 2000;68(2):68-75. (Pubitemid 30451562)
34. Lucas R, et al. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol. 1997;27(7):1719-1725. (Pubitemid 27302855)
35. Khader SA, et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med. 2006;203(7):1805-1815. (Pubitemid 44036285)
36. Redford PS, Murray PJ, O'Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 2011;4(3):261-270.
37. Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425-456. (Pubitemid 37174537)
38. De Smedt T, Van Mechelen M, De Becker G, Urbain J, Leo O, Moser M. Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol. 1997;27(5):1229-1235. (Pubitemid 27197228)
39. Webb DC, Cai Y, Matthaei KI, Foster PS. Comparative roles of IL-4, IL-13, and IL-4Rα in dendritic cell maturation and CD4+ Th2 cell function. J Immunol. 2007;178(1):219-227. (Pubitemid 46033604)
40. Islam N, et al. Role of cellular activation and tumor necrosis factor- ± in the early expression of Mycobacterium tuberculosis 85B mRNA in human alveolar macrophages. J Infect Dis. 2004;190(2):341-351. (Pubitemid 38951976)
41. Kim EY, Teh HS. TNF type 2 receptor (p75) lowers the threshold of T cell activation. J Immunol. 2001;167(12):6812-6820. (Pubitemid 33144172)
42. MacEwan DJ. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal. 2002;14(6):477-492. (Pubitemid 34230583)
43. Reis e Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med. 1993;178(2):509-519. (Pubitemid 23218199)
44. Bottomly K. T cells and dendritic cells get intimate. Science. 1999;283(5405):1124-1125.
45. Wolf AJ, et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med. 2008;205(1):105-115. (Pubitemid 351185719)
46. Bodnar KA, Serbina NV, Flynn JL. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect Immun. 2001;69(2):800-809. (Pubitemid 32109542)
47. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 2003;19(1):59-70. (Pubitemid 36859901)
48. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med. 1997;186(1):39-45. (Pubitemid 27304845)
49. de Jong R, Janson AA, Faber WR, Naafs B, Ottenhoff TH. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease. J Immunol. 1997;159(2):786-793. (Pubitemid 127484230)
50. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol. 2001;19:93-129. (Pubitemid 32368031)
51. Marino S, Pawar S, Fuller CL, Reinhart TA, Flynn JL, Kirschner DE. Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. J Immunol. 2004;173(1):494-506. (Pubitemid 38797377)
52. Flesch IE, Kaufmann SH. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun. 1990;58(8):2675-2677. (Pubitemid 20228256)
53. Pfeffer K, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 1993;73(3):457-467. (Pubitemid 23143346)
54. Erickson SL, et al. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature. 1994;372(6506):560-563.